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Non-adherence to medications remains a global crisis with high prevalence causing 
worsening health outcomes, increased morbidity, and even death. Multiple dimensions 
affect the medication-taking process ranging from patient-related determinants to 
health system causes. Many interventions to improve adherence have seen 
disappointingly modest improvements with the most effective strategies including 
multiple components. These interventions are normally delivered as a package without 
the full understanding of what are the most effective components. The Digital 
Revolution has put mHealth (mobile health) at the forefront of new, emerging tools for 
improved adherence. An approximate 200 new mHealth apps are added to the market 
each day with 46% of patients adapting mobile technology to improve their health in the 
previous twelve months. While the technical tools within apps such as dosage reminders 
have been proven effective, other components such as rewards and gamification have 
yet to be evaluated. The variety of components being offered also warrants an 
exploration of the opinions of their users. Through understanding effectiveness by 
adherence outcomes and users’ experiences within these mHealth offerings, a full 
understanding of their success and acceptability is possible. 
Objectives 
To explore, analyse and estimate the effect of interventions to improve medication 
adherence. This research aimed to gain a better understanding of the combination of 
components within effective interventions as well as evaluated an emerging mHealth 
tool, Perx Health. Simultaneously, beliefs, perceptions and experiences of users of the 
innovative mHealth intervention were explored to understand the acceptability and 
adoption of the technology. 
Methodology 
 iv 
A series of discrete studies were undertaken: (1) a network meta-analysis of studies 
assessing the effectiveness of interventions and their components aimed at improving 
medication adherence; (2) evaluation of the impact of an innovative mHealth 
intervention, Perx, utilising multiple components on sustaining optimal adherence 
levels; and (3) analysis of users’ beliefs, perceptions and experiences within the mHealth 
app for an understanding of the app’s desirability and adoption as a tool to improve 
adherence. 
Results 
The network meta-analysis identified 249 studies evaluating interventions to improve 
adherence over multiple periods of time. Multicomponent interventions were found to 
the be the most effective interventions at improving adherence over 10 months, with 
education in combination with technical and attitudinal components (OR 0.49, 95% CrI 
0.27-0.88) and rewards in combination with technical interventions having the most 
effective odds ratio (OR 0.03, 95% CrI 0.01-0.13) against standard of care. The Perx 
mHealth app utilising rewards, technical components, education and attitudinal 
components revealed high rates of adherence, average at 87.6% (SD 16.9%), above an 
optimal adherence threshold standard of 80%, over 6 months. An analysis of 6,296 user 
reviews of the mHealth app discovered a highly accepted and appreciated tool for aiding 
the management of medication adherence. Users reacted positively to reminder and 
reward components specifically, though expected improvements within technical 
functionality issues and the frequency of rewards. 
Conclusion 
Interventions to improve medication adherence have revealed modest improvements in 
effectiveness, with a continued need for multicomponent interventions to sustain 
adherence over 10 months. The evaluated mHealth intervention, Perx, utilising multiple 
components, including rewards, technical, education and attitudinal components, 
highlighted an intervention able to sustain optimal adherence rates over time. User 
reviews recognised a highly desirable and appreciated mHealth intervention in aiding 
the management of medication adherence. MHealth interventions should continue to 
v 
be innovated and adopted as helpful tools in improving medication adherence but must 
be evidence-based and evaluated for their effect on health outcomes. 
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Preface 
This thesis is presented in fulfilment of the doctoral degree (Doctor of Philosophy) 
requirements of the University of Technology Sydney, Australia.  
The thesis is structured as a PhD by compilation. Chapter 1 contains a research overview 
and  an outline of the overall rationale, objectives and organisation of the thesis. Chapter 
2 provides the background and reasoning for the research. Chapters 3-5 comprise the 
results including a network meta-analysis assessing comparative effectiveness of 
interventions to improve medication adherence, evaluation of a mobile health app’s 
impact on medication adherence and an exploration of user beliefs, perceptions and 
experiences using the aforementioned mobile health app. The chapters have been 
structured as research articles containing all corresponding references, figures, tables 
and appendices related to the research activity.  This is followed by Chapter 6, which 
discusses the results, summarises the contribution of work and provides 
recommendations for future research.  
Elyssa K Wiecek is the primary author of each publication. Additionally, co-authors 
contributed to the conception or design of the work, data collection, data analysis and 
interpretation, or revision of the manuscripts. 
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